Cargando...
EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples
AIMS: Activating mutations in the gene encoding epidermal growth factor receptor (EGFR) can confer sensitivity to EGFR tyrosine kinase inhibitors such as gefitinib in patients with advanced non-small-cell lung cancer. Testing for mutations in EGFR is therefore an important step in the treatment-deci...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Publishing Group
2013
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3582044/ https://ncbi.nlm.nih.gov/pubmed/23172555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jclinpath-2012-201194 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|